retatrutide pin Science's 2023 Breakthrough: GLP-1R Agonists Retatrutide: How to Get It
Description
BMJ Open 5 , e005892 (2015)
Wegovy is approved for weight loss and Ozempic is approved to treat type 2 diabetes mellitus
Challenges: GLP-1 receptor agonists face challenges impacting patient adherence, including gastrointestinal side effects like nausea and vomiting, which can deter use
Found is a telehealth service focused exclusively on weight loss
